Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 10/2022

01.04.2022 | Original Paper

Daily Associations Between Alcohol Consumption and Antiretroviral Therapy (ART) Adherence Among HIV-Positive Men Who Have Sex With Men

verfasst von: Alan Z Sheinfil, Jacklyn D. Foley, Dezarie Moskal, Michelle R. Dalton, Madison Firkey, Jeremy Ramos, Stephen A. Maisto, Sarah E. Woolf-King

Erschienen in: AIDS and Behavior | Ausgabe 10/2022

Einloggen, um Zugang zu erhalten

Abstract

Alcohol consumption is one of the strongest predictors of suboptimal adherence to antiretroviral therapy (ART), however, there is little research that has investigated both within- and between-person associations of alcohol consumption and ART adherence at the event-level. In this secondary data-analysis, (N = 22) HIV-positive MSM prospectively reported daily alcohol consumption and ART adherence for 42-days. Multilevel models demonstrated (1) days in which participants reported consuming any alcohol was associated with 2.48 increased odds of ART non-adherence, compared to days in which participants reported no alcohol consumption, and (2) there was a non-significant trend indicating days in which participants reported consuming greater than their own average levels of alcohol was associated with increased odds of ART non-adherence. Findings highlight the importance of combining intervention efforts that address alcohol consumption and suboptimal ART adherence, and indicate a need for future research to investigate the mechanisms by which alcohol influences ART adherence.
Literatur
1.
2.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Engl J Med. 2011 Aug;11(6):493–505.CrossRef
3.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016 Jul;12(2):171–81. 316.CrossRef
4.
Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009 Jun 10;301(22):2380–2.
5.
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009 Jan;3(9657):48–57.CrossRef
6.
Viswanathan S, Detels R, Mehta SH, Macatangay BJC, Kirk GD, Jacobson LP. Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART). AIDS Behav. 2015 Apr 1;19(4):601–11.
7.
Gordon LL, Gharibian D, Chong K, Chun H. Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types. AIDS Patient Care and STDs. 2015 Jun 4;29(7):384–8.
8.
Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdóttir TB, Richter C, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Medicine. 2014 Aug 21;12(1):142.
9.
Woolf-King SE, Sheinfil AZ, Ramos J, Foley JD, Moskal D, Firkey M, et al. A conceptual model of alcohol use and adherence to antiretroviral therapy: systematic review and theoretical implications for mechanisms of action. Health Psychology Review. 2020 Aug 6;0(0):1–32.
10.
Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: Review and meta-analysis. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180.
11.
Chander G, Lau B, Moore RD. Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack of Suppression in HIV Infection. J Acquir Immune Defic Syndr. 2006 Dec;43(4)(1):411–7.CrossRef
12.
Skeer MR, Mimiaga MJ, Mayer KH, O’Cleirigh C, Covahey C, Safren SA. Patterns of substance use among a large urban cohort of HIV-infected men who have sex with men in primary care. AIDS and behavior. 2012 Apr;16(3):676–89.CrossRef
13.
Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment. AIDS Behav. 2017 Jul;21(7):1914–25.CrossRef
14.
Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017 Apr;21(4):1138–48.CrossRef
15.
Kalichman SC, Horne R, Katner H, Hernandez D. Perceived sensitivity to medicines, alcohol interactive toxicity beliefs, and medication adherence among people living with HIV who drink alcohol. J Behav Med. 2019 Jun 1;42(3):392–400.
16.
Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007;3:1–27.CrossRef
17.
Tryon WW. Mediators and Mechanisms. Clinical Psychological Science. 2018 Sep 1;6(5):619–28.
18.
Parsons JT, Rosof E, Mustanski B. The Temporal Relationship Between Alcohol Consumption and HIV-Medication Adherence: A Multilevel Model of Direct and Moderating Effects. Health Psychol. 2008 Sep;27(5):628–37.
19.
Turner CM, Trujillo D, Le V, Wilson EC, Arayasirikul S. Event-Level Association Between Daily Alcohol Use and Same-Day Nonadherence to Antiretroviral Therapy Among Young Men Who Have Sex With Men and Trans Women Living With HIV: Intensive Longitudinal Study. JMIR Mhealth Uhealth [Internet]. 2020 Oct 15 [cited 2021 Jun 2];8(10). Available from: https://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC7596651/​.
20.
Arayasirikul S, Trujillo D, Turner CM, Le V, Wilson EC. Implementing a Digital HIV Care Navigation Intervention (Health eNav): Protocol for a Feasibility Study. JMIR Res Protoc. 2019 Nov;8(11):e16406.CrossRef
21.
Saunders JB, Aasland OG, Babor TF, Fuente JRDL, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791–804.CrossRef
22.
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. Audit. The Alcohol Use Disorders Identification Test (AUDIT): guidelines for use in primary care. 2001.
23.
Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, et al. Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence. AIDS Behav. 2008 Jan 1;12(1):86–94.
24.
Wilson IB, Fowler FJ, Cosenza CA, Michaud J, Bentkover J, Rana A, et al. Cognitive and Field Testing of a New Set of Medication Adherence Self-Report Items for HIV Care. AIDS Behav. 2014 Dec;18(12)(1):2349–58.CrossRef
25.
Muthén, LK, Muthén, BO (1998-2017). Mplus User’s Guide. In Eighth Edition. Muthén & Muthén.
26.
Pellowski JA, Kalichman SC, Kalichman MO, Cherry C. Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV. AIDS Care. 2016 Aug 2;28(8):963–70.
27.
28.
Snijders TAB, Bosker RJ. Standard Errors and Sample Sizes for Two-Level Research. Journal of Educational Statistics. 1993 Sep 1;18(3):237–59.
29.
De Boni RB, Zheng L, Rosenkranz SL, Sun X, Lavenberg J, Cardoso SW, et al. Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals. Drug Alcohol Depend. 2016 Feb;1:159:174–80.CrossRef
30.
Kenya S, Chida N, Jones J, Alvarez G, Symes S, Kobetz E. Weekending in PLWH: Alcohol Use and ART Adherence, A Pilot Study. AIDS Behav. 2013 Jan;1(1):61–70.CrossRef
31.
Genberg BL, Lee Y, Rogers WH, Wilson IB. Four Types of Barriers to Adherence of Antiretroviral Therapy are Associated with Decreased Adherence Over Time. AIDS Behav. 2015 Jan 1;19(1):85–92.
32.
Wilson IB, Bangsberg DR, Shen J, Simoni JM, Reynolds NR, Goggin K, et al. Heterogeneity among studies in rates of decline of ART adherence over time: Results from the MACH14 study. J Acquir Immune Defic Syndr. 2013 Dec;15(5):448–54.CrossRef
33.
Ghidei L, Simone MJ, Salow MJ, Zimmerman KM, Paquin AM, Skarf LM, et al. Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected Individuals. Drugs Aging. 2013 Oct 1;30(10):809–19.
34.
Bolger N, Laurenceau J-P. Intensive Longitudinal Methods: An Introduction to Diary and Experience Sampling Research. Guilford Press; 2013. 274 p.
35.
El-Krab R, Kalichman SC. Alcohol-Antiretroviral Therapy Interactive Toxicity Beliefs and Intentional Medication Nonadherence: Review of Research with Implications for Interventions. AIDS Behav [Internet]. 2021 May 5 [cited 2021 Jul 18]; Available from: https://​doi.​org/​10.​1007/​s10461-021-03285-x.
36.
37.
Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2017 Apr 3;29(4):418–22.
38.
39.
Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, et al. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS Behav. 2020 Jan 1;24(1):284–90.
40.
41.
Madhombiro M, Musekiwa A, January J, Chingono A, Abas M, Seedat S. Psychological interventions for alcohol use disorders in people living with HIV/AIDS: a systematic review. Syst Rev. 2019 Oct 28;8(1):244.
42.
Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B, et al. Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial. J Consult Clin Psychol. 2018 Aug;86(8):645–56.CrossRef
43.
Sikkema KJ, Hansen NB, Kochman A, Santos J, Watt MH, Wilson PA, et al. The development and feasibility of a brief risk reduction intervention for newly HIV-diagnosed men who have sex with men. J Community Psychol. 2011 Aug 1;39(6):717–32.
44.
Velasquez MM, von Sternberg K, Johnson DH, Green C, Carbonari JP, Parsons JT. Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial. J Consult Clin Psychol. 2009 Aug;77(4):657–670.CrossRef
45.
Hasin D, Aharonovich E, Zingman B, Stohl M, Walsh C, Elliott JC, et al. HealthCall: Smartphone Enhancement of Brief Interventions to Improve Medication Adherence Among Patients in HIV care. medRxiv. 2020 Nov 26;2020.11.25.20235788.
46.
Quinn KG, Voisin DR. ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities. Curr HIV/AIDS Rep. 2020 Aug 1;17(4):290–300.
47.
Woolf-King SE, Sheinfil AZ, Babowich JD, Siedle-Khan B, Loitsch A, Maisto SA. Acceptance and Commitment Therapy (ACT) for HIV-infected Hazardous Drinkers: A Qualitative Study of Acceptability. Alcoholism Treatment Quarterly. 2019 Jul 3;37(3):342–58.
48.
Simmons EM, Firkey MK, Sheinfil AZ, Ramos JM, Woolf-King SE. The Association Between Financial Resources Strain and Self-Reported Antiretroviral Therapy (ART) Adherence among HIV-Positive Men Who Have Sex with Men. Journal of Health Care for the Poor and Underserved. 2021;32(4):2222–32.
49.
Firkey M, Sheinfil A, Ramos J, Woolf-King SE. Cannabis and Alcohol Co-Use and Condomless Anal Sex Among Men Who have Sex with Men Living with HIV: An Event-Level Analysis. AIDS Behav. 2021 Nov 1;25(11):3770–81.
50.
Sewell J, Daskalopoulou M, Nakagawa F, Lampe F, Edwards S, Perry N, et al. Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment. HIV Medicine. 2017;18(7):463–73.
Metadaten
Titel
Daily Associations Between Alcohol Consumption and Antiretroviral Therapy (ART) Adherence Among HIV-Positive Men Who Have Sex With Men
verfasst von
Alan Z Sheinfil
Jacklyn D. Foley
Dezarie Moskal
Michelle R. Dalton
Madison Firkey
Jeremy Ramos
Stephen A. Maisto
Sarah E. Woolf-King
Publikationsdatum
01.04.2022
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 10/2022
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-022-03657-x

Weitere Artikel der Ausgabe 10/2022

AIDS and Behavior 10/2022 Zur Ausgabe

Original Paper

Engagement in HIV care and viral suppression following changes in long-term opioid therapy for treatment for chronic pain

Original Paper

The Long-term (5-year) Impact of a Family Economic Empowerment Intervention on Adolescents Living with HIV in Uganda: Analysis of Longitudinal Data from a Cluster Randomized Controlled Trial from the Suubi+Adherence Study (2012–2018)

Original Paper

Pre-exposure Prophylaxis (PrEP) Initiation Among Black and Latina Cisgender Women Receiving HIV Prevention Care Coordination Services in New York City

Original Paper

Economic vulnerability, violence, and sexual risk factors for HIV among female sex workers in Tijuana, Mexico

Original Paper

Characterizing Ryan White Part A-funded support service utilization patterns and their association with viral suppression among people with HIV in New York City

Original Paper

Predictors of HIV Among 1 Million Clients in High-Risk Male Populations in Tanzania

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise